The Microbiota-Gut-Brain Axis in Neuropsychiatric Disorders: Pathophysiological Mechanisms and Novel Treatments

Abstract

BackgroundThe human gut microbiome comprise a huge number of microorganisms with co-evolutionary associations with humans. It has been repeatedly revealed that bidirectional communication exists between the brain and the gut and involves neural, hormonal, and immunological pathways. Evidences from neuroscience researches over the past few years suggest that microbiota is essential for the development and maturation of brain systems that are associated to stress responses.MethodThis review provides that the summarization of the communication among microbiota, gut and brain and the results of preclinical and clinical studies on gut microbiota used in treatments for neuropsychiatric disorders.ResultRecent studies have reported that diverse forms of neuropsychiatric disorders (such as autism, depression, anxiety, and schizophrenia) are associated with or modulated by variations in the microbiome, by microbial substrates, and by exogenous prebiotics, antibiotics, and probiotics.ConclusionThe microbiota–gut–brain axis might provide novel targets for prevention and treatment of neuropsychiatric disorders. However, further studies are required to substantiate the clinical use of probiotics, prebiotics and FMT.

Could Gut Modulation through Probiotic Supplementation Be Beneficial in Autism Spectrum Disorder?

“…The exact mechanisms of signal transmission within this network are not completely elucidated. The CNS asserts its role over the GM through influencing gut motility patterns, altering the equilibrium in the gut permeability, and modulating mucus secretion which are known to exert control over gut microbial composition [5]. Conversely, the GM claims its influence over the CNS by regulating the hypothalamic-pituitary-adrenal axis and the production and turnover of cytokines and neurotransmitters.…”

Physical activity regulates the intestinal microbiota composition

“…Alterations in microbiota composition are associated with the onset of autoimmune and allergic diseases including multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus, psoriasis, atopic dermatitis and food allergies (Tanaka & Nakayama, 2017;McKenzie, Tan, Macia & Mackay, 2017). Gut microbiota dysbiosis may be involved in the pathophysiology of neuropsychiatric disorders (depression, schizophrenia, autism spectrum disorder, dementia, Alzheimer's and Parkinson's disease (Ghaisas, Maher & Kanthasamy, 2016;Kim & Shin, 2018), kidney diseases (Knauf, Brewer & Flavell, 2019), osteoporosis (Ohlsson & Sjogren, 2015) and liver cirrhosis (Qin et al, 2014).…”

Multiple sclerosis - new therapeutic directions

“…In addition, stimulation of efferent signaling nerves can regulate immune cell activity [125]. The role of this gut-brain axis has been implied in pathophysiology of psychiatric and neurological disorders such as MS [126].…”